Nuchev expands commercial role with H&S distribution agreement
Nuchev Limited (ASX: NUC) has transitioned from an agency arrangement to a full distribution agreement with H&S Global (Au) Pty Ltd, marking an evolution of the partnership originally announced on 1 May 2025. The Nuchev H&S Distribution Agreement, signed on 4 March 2026, expands the company’s commercial role across three established brands: Brauer, Skin Physics, and Rapid Loss.
The shift to a distribution model provides Nuchev with greater control over brand execution, pricing, and market development, while improving margins and enabling operating leverage as scale builds. This structure aligns with the company’s strategy to scale its brand portfolio across growing health, wellness, and beauty categories and build operating scale to support its pathway to profitability.
Under the distribution model, Nuchev will record gross sales and assume responsibility for inventory and receivables associated with the brands. While this structure increases working capital requirements, it improves margin capture and creates operating leverage as volumes grow.
Join thousands of readers who start here
Our best articles, sent straight to your inbox. You can unsubscribe anytime.
What is a distribution agreement and why does it matter?
A distribution agreement gives a company full ownership of the sales process, including inventory management, pricing control, and customer receivables. This differs from an agency model, where the company acts as a sales agent and earns commission-based revenue without owning inventory or controlling pricing.
For Nuchev’s specific situation, the transition means taking on more responsibility but capturing more value per sale. The agency model provided lower-risk commission income, whilst the distribution model allows the company to record full gross sales and retain the margin difference between wholesale cost and retail price.
Distribution agreements typically improve gross margins but require greater working capital investment. For companies seeking profitability, this trade-off can accelerate earnings growth as volumes scale, provided the business can manage the increased operational complexity and cash flow requirements effectively.
The key differences between the two models include:
- Revenue recognition – Agency model records commissions only, whilst distribution model records full gross sales
- Margin capture – Agency earns a percentage, distribution retains the full margin after costs
- Operational control – Distribution provides direct control over pricing, inventory levels, and customer relationships
Three growth brands across health, wellness and beauty
The agreement expands Nuchev’s commercial role across three established brands operating in complementary consumer segments:
- Brauer – A trusted practitioner and retail wellness brand with strong heritage and brand recognition
- Skin Physics – A science-led beauty brand positioned in high-growth skin health categories
- Rapid Loss – A performance nutrition and weight management brand with strong consumer demand
Together, these brands operate in attractive and expanding consumer segments supported by long-term health, wellness, and self-care trends. Portfolio diversification across three distinct but complementary categories reduces single-brand risk whilst providing exposure to multiple growth vectors within the broader wellness market.
Strategic benefits of the new structure
Transitioning to a distribution model strengthens Nuchev’s commercial platform and supports the company’s strategy to deliver sustainable, profitable growth. The structure provides several operational advantages that improve alignment between revenue growth and earnings contribution.
The company outlined five key strategic benefits in its announcement to the ASX:
- Improved margins across the brand portfolio
- Increased operating leverage as volumes scale
- Stronger control over brand execution and market performance
- Enhanced alignment between sales growth and earnings growth
- A scalable platform to support future expansion
| Factor | Agency Model | Distribution Model | Benefit to Nuchev |
|---|---|---|---|
| Margin capture | Commission only | Full gross margin | Higher profitability per sale |
| Brand control | Limited | Direct | Better market execution |
| Working capital | Low | Higher | Necessary trade-off for margin |
| Scalability | Constrained | High | Operating leverage at volume |
As volumes scale, the fixed costs associated with distribution infrastructure become more efficient, creating operating leverage that improves profitability. This structure positions Nuchev to translate revenue growth more directly into earnings improvement, supporting the company’s pathway to profitability.
Financial considerations and implementation timeline
The distribution model requires increased working capital investment compared to the agency arrangement. Nuchev will assume responsibility for inventory and receivables associated with the three brands, which increases short-term cash requirements but enables the company to capture full margins rather than commission-based revenue.
This represents an investment in future margin capture rather than a structural burden. Higher working capital demands in the short term should translate to improved margin contribution as volumes grow, supporting the company’s profitability pathway whilst building a more scalable commercial platform.
Implementation will occur rapidly and in a structured manner to ensure continuity of supply and customer service. Nuchev is working closely with H&S and operational partners to deliver a smooth transition and maintain strong service levels across customers and channels. The phased approach aims to minimise disruption whilst capturing the strategic benefits of the new structure.
CEO outlook
Nathan Cheong, Chief Executive Officer
“This Agreement is an important step forward for Nuchev. It gives us greater control over how our brands are executed in market, improves margins, and creates the operating leverage we need as we scale. Brauer, Skin Physics and Rapid Loss are strong brands in growing categories, and this structure positions us to build scale and move toward profitability while supporting long-term growth.”
Enjoyed this article?
We publish high-impact stories like this a few times a week. No spam.
Investment thesis for Nuchev’s distribution pivot
The transition to a distribution model represents Nuchev’s commitment to building a scalable commercial platform with improved unit economics. The Nuchev H&S Distribution Agreement builds on the successful agency arrangement announced in May 2025, indicating operational confidence in the partnership and the brand portfolio’s market performance.
The agreement aligns with broader consumer trends supporting health, wellness, and beauty categories. By assuming greater operational responsibility, Nuchev positions itself to capture more value per sale whilst building infrastructure that can support future brand expansion. Success will be measured by margin expansion and revenue growth translating more directly to earnings improvement.
For investors, the key metrics to monitor include gross margin performance, working capital efficiency, and the rate at which operating leverage delivers improved profitability. The structure creates a more direct pathway between top-line growth and bottom-line contribution, provided the company can manage the increased operational complexity effectively.
The agreement strengthens Nuchev’s position within the health and wellness sector by providing greater control over brand execution, pricing, and market development. As the company scales its operations across Brauer, Skin Physics, and Rapid Loss, the distribution model should support its stated pathway to profitability whilst maintaining flexibility for future brand partnerships.
Want the Next Consumer Breakthrough in Your Inbox?
Join 20,000+ investors receiving FREE breaking ASX news within minutes of release, complete with in-depth analysis. Click the “Free Alerts” button at Big News Blast to get consumer sector announcements the moment they hit the market, with expert coverage already done for you.